PAR 1.96% 25.0¢ paradigm biopharmaceuticals limited..

Are you referring to a clinical hold? The company has not...

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    Are you referring to a clinical hold? The company has not confirmed to the market that PAR is in a clinical hold and if they were then the FDA is obligated to notify PAR of this in writing soon after the phone call along with their concerns, and I would imagine PAR would also have to notify the market.

    It appears the FDA simply needs time to ask questions outside the 30-day period.

    We'll find out next week.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.